Targeting a human protein to squash SARS-CoV-2 and other viruses (IMAGE)
Caption
Apratoxin S4 (structure shown here) is effective against SARS-CoV-2 in human cells and could be a pan-viral therapeutic.
Credit
Adapted from ACS Infectious Diseases 2022, DOI: 10.1021/acsinfecdis.2c00008
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.
License
CC BY-NC-ND